Clinical trial
Functional Dyspepsia Treatment Trial
NCT00248651 · Mayo Clinic, Other · Completed
Key facts
| NCT number | NCT00248651 |
|---|---|
| Title | Functional Dyspepsia Treatment Trial |
| Official title | Antidepressant Therapy for Functional Dyspepsia |
| Acronym | FDTT |
| Lead sponsor | Mayo Clinic, Other |
| Collaborators | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) NIH |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Dyspepsia and Other Specified Disorders of Function of Stomach |
| Intervention type | Drug |
| Interventions | Amitriptyline, Escitalopram, Placebo |
| Enrollment | 292 |
| Start date | Oct 1, 2006 |
| Primary completion | Jul 1, 2013 |
| Completion | Jul 1, 2013 |
| First posted | Nov 4, 2005 |
| Last update posted | Jul 25, 2014 |
| Countries | Canada, United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: